Einträge von Yanik, Gregory auf dem Publikationsserver

Al Malki, Monzr M., London, Kaitlyn, Baez, Janna, Akahoshi, Yu , Hogan, William J. , Etra, Aaron, Choe, Hannah, Hexner, Elizabeth , Langston, Amelia , Abhyankar, Sunil, Ponce, Doris M., DeFilipp, Zachariah, Kitko, Carrie L., Adekola, Kehinde, Reshef, Ran, Ayuk, Francis, Capellini, Alexandra, Chanswangphuwana, Chantiya, Eder, Matthias, Eng, Gilbert, Gandhi, Isha, Grupp, Stephan, Gleich, Sigrun, Holler, Ernst, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kowalyk, Steven, Morales, George, Özbek, Umut, Rösler, Wolf, Spyrou, Nikolaos, Yanik, Gregory, Young, Rachel, Chen, Yi-Bin, Nakamura, Ryotaro, Ferrara, James L. M. und Levine, John E. (2023) Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances 7 (17), S. 5189-5198. Volltext nicht vorhanden.

Zewde, Makda Getachew, Morales, George, Gandhi, Isha, Özbek, Umut, Aguayo-Hiraldo, Paibel, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Choe, Hannah, DeFilipp, Zachariah, Etra, Aaron, Grupp, Stephan, Hexner, Elizabeth O., Hogan, William, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kitko, Carrie L., Kowalyk, Steven, Meedt, Elisabeth, Merli, Pietro, Nakamura, Ryotaro, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Weber, Daniela, Wölfl, Matthias, Yanik, Gregory, Young, Rachel, Levine, John E., Ferrara, James L. M. und Chen, Yi-Bin (2021) Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplantation and Cellular Therapy 27 (12), 988.e1-988.e7. Volltext nicht vorhanden.

Aziz, Mina D., Shah, Jay, Kapoor, Urvi, Dimopoulos, Christina, Anand, Sarah, Augustine, Allan, Ayuk, Francis, Chaudhry, Mohammed, Chen, Yi-Bin, Choe, Hannah K., Etra, Aaron, Gergoudis, Stephanie, Hartwell, Matthew J. , Hexner, Elizabeth O., Hogan, William J., Kitko, Carrie L., Kowalyk, Steven, Kröger, Nicolaus, Merli, Pietro , Morales, George, Nakamura, Ryotaro, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran , Rösler, Wolf, Schechter, Tal, Schreiner, Elisabeth, Srinagesh, Hrishikesh, Wölfl, Matthias, Wudhikarn, Kitsada, Yanik, Gregory, Young, Rachel, Özbek, Umut, Ferrara, James L. M. und Levine, John E. (2020) Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia 34 (7), S. 1898-1906. Volltext nicht vorhanden.

Holtan, Shernan G., Khera, Nandita, Levine, John E., Chai, Xiaoyu, Storer, Barry, Liu, Hien D., Inamoto, Yoshihiro, Chen, George L., Mayer, Sebastian, Arora, Mukta, Palmer, Jeanne, Flowers, Mary E. D., Cutler, Corey S., Lukez, Alexander, Arai, Sally, Lazaryan, Aleksandr, Newell, Laura F., Krupski, Christa, Jagasia, Madan H., Pusic, Iskra, Wood, William, Renteria, Anne S., Yanik, Gregory, Hogan, William J., Hexner, Elizabeth, Ayuk, Francis, Holler, Ernst, Watanaboonyongcharoen, Phandee, Efebera, Yvonne A., Ferrara, James L. M., Panoskaltsis-Mortari, Angela, Weisdorf, Daniel, Lee, Stephanie J. und Pidala, Joseph (2016) Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood 128 (19), S. 2350-2358. Volltext nicht vorhanden.